Pricing

Log inSign up

Alnylam Pharmaceuticals

23 followers

‌

Alnylam is the world's leading RNAi therapeutics company and the first and only company to bring an RNAi medicine to market.

Industries

Pharmaceutical

Headquarters

Cambridge, United States

Employees

1,001-5,000

Links

Org chart

Yvonne Greenstreet
CEO

Yvonne Greenstreet

Collapse
Pushkal Garg
Chief Medical Officer
Jeff Poulton
CFO
Vasant Jadhav
Chief Technology Officer
Tolga Tanguler
CCO
Kevin Fitzgerald
Chief Scientific Officer
Evan Lippman
Chief Corporate Development & Strategy Officer
Kelley Boucher
Chief Human Resource Officer
Timothy Maines
Chief Technical Operations & Quality Officer
Christine Lindenboom
Chief Corporate Communications Officer
Kasha Witkos
SVP, International Region Head
Julie Milner
VP Head Of International Regulatory Affairs
Priya Sankar
Vice President, General Counsel, Global Research & Development
Jake Carleton
Legal Director
Robert Hesslein
Chief Legal Officer & Corporate Secretary
MT
Mike Tirozzi
Svp, Chief Information And Data Officer

Board & advisors

AS
Amy W. Schulman
Chair
Colleen Reitan
Director
David E.i. Pyott
Board Member
DA
Dennis A. Ausiello
Director
MH
Margaret A. Hamburg
Director
MB
Michael W. Bonney
Director
OB
Olivier Brandicourt
Director
PS
Phillip A. Sharp
Director
ES
Elliott Sigal
Director
PK
Peter N. Kellogg
Director
CB
Carolyn Bertozzi
Director

Teams

+51

Leadership Team

54 members

+48

Research and Development

51 members

+17

Clinical Operations

20 members

+12

Finance and Accounting

15 members

+11

Human Resources and Talent Management

14 members

+7

Data Analytics and Engineering

10 members

Offices

Similar companies

PCI Pharma Services

7 followers

CONMED

2 followers

ProPharma Group

2 followers

Novavax

10 followers

Phibro Animal Health

5 followers

EVERSANA

5 followers

PharmaCord

1 follower

Masimo

9 followers

Propel Health

1 follower

Bristol-Myers Squibb

209 followers

VIRIXENE

123 followers

Explore companies